Innovative 3D in vitro tissue-on-a-chip models using RGD-functionalized hydrogels to mimic the extracellular environment, offering realistic responses in screening assays. The platform supports scalability from manual to robotic liquid handling.
CBio introduces a cutting-edge 3D follicle and skin-on-a-chip model that leverages RGD-functionalized hydrogels to closely mimic the natural extracellular environment. This technology provides a more realistic response in screening assays compared to conventional in vitro models on bare plastic plates. It's designed for high throughput, allowing large-scale and varied treatment applications, making it ideal for testing drug interactions and other biological assays.
Currently at TRL 2, this technology is in the early validation phase. Further development will focus on functionalizing hydrogels to mimic the skin or follicle microenvironment and refining treatment application protocols. The project aims to reach a proven application ready for scaling within 10 months.